Skip to main content

Table 1 Main characteristics of the studies included in the meta-analysis (n = 40)

From: Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis

Study

Total number of patients in study

Patient response categorya

Age category (age restrictions)b

GnRH agonist, GnRH antagonist or both

Insemination technique

Starting dose

Stimulation day (r-hLH initiated)

      

r-hFSH (IU)

r-hLH (IU)

 

Williams 2000 [47]

60

Normal

None

Agonist

IVF/ICSI

300

25

 

MS8839 [48]

76

Normal

None

Agonist

IVF

150

75

1

MS9032 [49]

45

Normal

None

Agonist

ICSI

c

75

1

MS9029 [50]

42

Poor

None

Agonist

ICSI

450

75

1

Balasch 2001 [51]

30

Normal

None

Agonist

IVF/ICSI

450

75

1

MS9640 [52]

141

Normal

None

Agonist

IVF/ICSI

225

75

1

Lisi 2002a [53]

453

Poor

None

Agonist

IVF

225

75

7

Lisi 2002b [54]

22

Normal

None

Agonist

IVF/ICSI

150

75

7

De Moustier 2002 [55]

169

Normal

Advanced

Agonist

IVF

225

c

 

Ludwig 2003 [56]

20

Normal

None

Antagonist

IVF/ICSI

 

75

 

Sauer 2004 [57]

42

Normal

None

Antagonist

ICSI

225

150

7

Cedrin-Durnerin 2004 [58]

203

Normal

None

Antagonist

IVF/ICSI

c

75

 

Ferraretti 2004 [10]

108

Poor

None

Agonist

IVF/ICSI

c

c

 

Humaidan 2004 [23]

231

Normal

Two subgroups

Agonist

IVF/ICSI

c

c

8

Marrs 2004 [25]

431

Normal

Two subgroups

Agonist

ICSI

225

150

6

Motta 2005 [27]

102

Poor

None

Both

IVF/ICSI

 

75

 

Griesinger 2005 [59]

127

Normal

None

Antagonist

IVF/ICSI

150

75

1

Demirol 2005 [60]

106

Poor

None

Antagonist

ICSI

450

150

1

De Placido 2005 [61]

130

Poor

None

Agonist

IVF/ICSI

225

150

8

Tarlatzis 2006 [62]

114

Normal

None

Agonist

IVF/ICSI

150

75

 

Ramirez 2006 [63]

34

Poor

None

Antagonist

IVF/ICSI

c

150

 

Levi-Setti 2006 [64]

40

Normal

None

Antagonist

ICSI

225

75

 

Abdelmassih 2006 [65]

206

Normal

None

Agonist

IVF/ICSI

225

75

7

Aytac 2006 [66]

35

Poor

None

Agonist

ICSI

 

150

 

Fabregues 2006 [67]

120

Normal

Advanced

Agonist

IVF/ICSI

c

150

6

Ruvolo 2007 [68]

42

Poor

None

Agonist

IVF/ICSI

225

c

8

Polidoropoulos 2007 [69]

136

Poor

None

Agonist

ICSI

450

75

 

Berkkanoglu 2007 [70]

97

Normal

None

Agonist

ICSI

600

75

7

Nyboe Andersen 2008 [24]

526

Normal

Two subgroups

Agonist

IVF/ICSI

c

c

7

Barrenetxea 2008 [71]

84

Poor

Advanced

Agonist

ICSI

375

150

6

Pezzuto 2010 [72]

80

Normal

None

Agonist

ICSI

c

75

6

Brunet 2009 [73]

94

Poor

None

Agonist

IVF

 

75

8

Gutman 2009 [74]

20

Normal

None

Agonist

IVF/ICSI

c

75

 

Matorras 2009 [75]

131

Normal

Advanced

Agonist

ICSI

c

150

6

Lahoud 2010 [76]

103

Normal

None

Agonist

IVF/ICSI

 

75

7

Kovacs 2010 [77]

50

Normal

None

Agonist

IVF/ICSI

150

75

1

Wiser 2011 [78]

30

Normal

None

Antagonist

IVF/ICSI

c

75

 

Musters 2012 [79]

244

Poor

Advanced

Agonist

IVF/ICSI

c

c

1

Caserta 2011 [80]

999

Normal

None

Agonist

ICSI

150

75

7

Bosch 2011 [26]

720

Normal

Two subgroups

Antagonist

IVF/ICSI

c

75

6

Total

6443

       
  1. aNormal = normal ovarian response, poor = poor/risk of poor ovarian response.
  2. bAdvanced = advanced maternal age, two subgroups = study had two age-based subgroups.
  3. cStarting dose varied according to numerous factors, such as patient age or body mass index; blank spaces indicate that the data were not reported by the study author.
  4. GnRH, gonadotrophin-releasing hormone; ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilization; r-hFSH, recombinant human follicle-stimulating hormone; r-hLH, recombinant human luteinizing hormone.
  5. Note: the study by Musters et al. was included in the analysis prior to its publication in 2012.